Cullinan Therapeutics, Inc. - Common Stock (CGEM)
CUSIP: 230031106
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,091,689
- Total 13F shares
- 36,386,962
- Share change
- +892,194
- Total reported value
- $559,714,828
- Price per share
- $15.43
- Number of holders
- 74
- Value change
- +$6,266,769
- Number of buys
- 41
- Number of sells
- 24
Quarterly Holders Quick Answers
What is CUSIP 230031106?
CUSIP 230031106 identifies CGEM - Cullinan Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230031106:
Top shareholders of CGEM - Cullinan Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MPM BioImpact LLC |
13F
|
Company |
13%
|
7,648,268
|
$172,621,000 | — | 30 Sep 2021 | |
| UBS Oncology Impact Fund L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
7,648,268
|
$95,297,419 | — | 16 Sep 2021 | |
| Foresite Capital Management V, LLC |
13F
|
Company |
4.6%
|
2,731,410
|
$61,648,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
4.2%
|
2,500,202
|
$56,430,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
2,281,451
|
$51,492,000 | — | 30 Sep 2021 | |
| CHI Advisors LLC |
13F
|
Company |
3.8%
|
2,244,841
|
$50,666,000 | — | 30 Sep 2021 | |
| BAUPOST GROUP LLC/MA |
13F
|
Company |
3.1%
|
1,835,560
|
$40,237,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.8%
|
1,629,594
|
$36,780,000 | — | 30 Sep 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
1,440,145
|
$31,690,000 | — | 30 Sep 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
2.1%
|
1,237,877
|
$27,939,000 | — | 30 Sep 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.9%
|
1,146,145
|
$25,868,000 | — | 30 Sep 2021 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.8%
|
1,075,912
|
$24,283,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
1.8%
|
1,074,082
|
$24,242,000 | — | 30 Sep 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.8%
|
1,044,000
|
$23,563,000 | — | 30 Sep 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.3%
|
776,406
|
$17,524,000 | — | 30 Sep 2021 | |
| BVF INC/IL |
13F
|
Company |
1.2%
|
735,106
|
$16,591,000 | — | 30 Sep 2021 | |
| VR Adviser, LLC |
13F
|
Company |
1.2%
|
706,050
|
$15,936,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.8%
|
475,058
|
$10,722,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
421,238
|
$9,507,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.61%
|
362,959
|
$8,192,000 | — | 30 Sep 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.59%
|
350,000
|
$7,900,000 | — | 30 Sep 2021 | |
| Logos Global Management LP |
13F
|
Company |
0.49%
|
288,458
|
$6,510,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
229,003
|
$5,168,000 | — | 30 Sep 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.35%
|
207,030
|
$4,673,000 | — | 30 Sep 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.33%
|
193,192
|
$4,360,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.29%
|
170,744
|
$3,854,000 | — | 30 Sep 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.27%
|
157,501
|
$3,555,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.18%
|
106,133
|
$2,395,000 | — | 30 Sep 2021 | |
| Artal Group S.A. |
13F
|
Company |
0.17%
|
100,000
|
$2,257,000 | — | 30 Sep 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.14%
|
81,418
|
$1,838,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
80,164
|
$1,810,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
70,786
|
$1,599,000 | — | 30 Sep 2021 | |
| Birchview Capital, LP |
13F
|
Company |
0.08%
|
45,114
|
$1,018,000 | — | 30 Sep 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.06%
|
35,858
|
$809,000 | — | 30 Sep 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.05%
|
32,250
|
$728,000 | — | 30 Sep 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.05%
|
31,025
|
$700,000 | — | 30 Sep 2021 | |
| MIRABELLA FINANCIAL SERVICES LLP |
13F
|
Company |
0.05%
|
29,686
|
$670,000 | — | 30 Sep 2021 | |
| Swiss National Bank |
13F
|
Company |
0.05%
|
28,600
|
$646,000 | — | 30 Sep 2021 | |
| DARK FOREST CAPITAL MANAGEMENT LP |
13F
|
Company |
0.04%
|
25,409
|
$573,000 | — | 30 Sep 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
24,668
|
$557,000 | — | 30 Sep 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.03%
|
17,100
|
$386,000 | — | 30 Sep 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
15,863
|
$358,000 | — | 30 Sep 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
15,202
|
$343,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
15,133
|
$341,000 | — | 30 Sep 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
13,800
|
$311,000 | — | 30 Sep 2021 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
13,682
|
$309,000 | — | 30 Sep 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.02%
|
12,212
|
$276,000 | — | 30 Sep 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
11,848
|
$267,000 | — | 30 Sep 2021 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
9,808
|
$221,367 | — | 30 Sep 2021 | |
| BAILARD, INC. |
13F
|
Company |
0.02%
|
9,600
|
$217,000 | — | 30 Sep 2021 |
Institutional Holders of Cullinan Therapeutics, Inc. - Common Stock (CGEM) as of Q4 2021
As of 31 Dec 2021,
Cullinan Therapeutics, Inc. - Common Stock (CGEM) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,386,962 shares.
The largest 10 holders included
BIOIMPACT CAPITAL LLC, BVF INC/IL, CHI Advisors LLC, VANGUARD GROUP INC, BlackRock Inc., BAUPOST GROUP LLC/MA, EVENTIDE ASSET MANAGEMENT, LLC, AMERICAN INTERNATIONAL GROUP, INC., Nextech Invest AG, and STATE STREET CORP.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
63
Q4 2021 holders
74
Holder diff
11
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.